@FierceMedDev: Alere has reached a deal with the FDA on Dx production, looking to move past May's recall of 800K test kits. More | Follow @FierceMedDev
@MarkHFierce: Sony may be boosting its involvement in med tech, but investors are worried the company is going down a sinkhole. More | Follow @MarkHFierce
@DamianFierce: Medtronic's next-gen renal denervation device takes a page from the St. Jude tech Medtronic earlier dismissed. More | Follow @DamianFierce
> Johnson & Johnson ($JNJ)/Ethicon says it is rolling out new wound closure surgical devices as part of its Stratafix line. Release
> Covidien ($COV) has nailed down a 510(k) clearance and CE mark for a new bedside respiratory patient monitoring system. Release
> BioBehavioral Diagnostics has raised $1 million in new financing to help fuel marketing of its ADHD diagnostic. Story
> Penn State scientists believe they are a few steps away from creating a medical analytic device like Star Trek's tricorder, having figured out how to use acoustic waves to sort cells on a chip. Story
> Two new studies have determined that gene sequencing can lead to a quicker diagnosis of rare genetic disorders in newborns. Also, the process can determine mental retardation causes in tough cases, Bloomberg reports. Story
> Volcano Corp. ($VOLC) said it won 510(k) clearance and a CE mark to start marketing its new digital IVUS catheter for the treatment of peripheral vascular disease. Release
> Creganna-Tactx Medical, an Irish medical device outsourcer, has snatched up ABT Medical, a maker of medical balloons for a variety of medical devices made by other companies. Release
> ERBA Diagnostics has snatched up Escalon Medical's clinical diagnostics business for $6.5 million in cash. Release
Biotech News
@FierceBiotech: Merger deal gives generic drugmaker control of troubled BioSante. More | Follow @FierceBiotech
@JohnCFierce: 2012 Fierce 15 winner Aragon raises $50M for 509 program. That's 88M this year. More | Follow @JohnCFierce
@RyanMFierce: BioSante goes the way of the M&A. More | Follow @RyanMFierce
> Report: Biosimilars team at Teva/Lonza slam the brakes on Rituxan knockoff. Article
> Momenta Pharma options antibody against red meat-related inflammation. Story
Pharma News
@FiercePharma: J&J's trying to block testimony from ex-FDA chief David Kessler, who calls its Risperdal marketing "deeply troubling." More | Follow @FiercePharma
> Teva yanks Wellbutrin copy after FDA says it's not equivalent to brand. News
> India nixes Pfizer's patent on cancer-fighter Sutent. Story
> Mylan sues FDA to revoke Ranbaxy's Diovan exclusivity. Report
Pharma Manufacturing News
> Merck whacking 20% of jobs at Ireland API plant. Story
> New Janssen distribution hub consolidates European supply chain. Article
Vaccines News
> Novartis vaccines unit's future hangs on Bexsero approval. Article
> NIH awards $1.38M to professor for HIV vaccine research. Item
> Merck's Gardasil earns high safety marks. Story
> Flu vaccine manufacturers face steep odds. News
And Finally... Cadence Biomedical has begun selling a medical device, inspired by horses, that's intended to help patients who have trouble walking gain more routine mobility. Story